{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T14:21:00Z","timestamp":1788618060717,"version":"build-2803163510"},"reference-count":12,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T00:00:00Z","timestamp":1628640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:p>Reactive arthritis (ReA) is an immune-mediated aseptic synovitis resulting either from genitourinary or gastrointestinal tract, commonly presenting as oligoarthritis of the lower limbs and rarely urethritis and conjunctivitis. The treatment options include nonsteroidal anti-inflammatory drugs, conventional disease-modifying antirheumatic drugs, and biologics in severe cases. We report successful use of secukinumab in two cases of chronic severe ReA who initially failed to treatment with tumour necrosis factor inhibitor.<\/jats:p>","DOI":"10.1093\/mrcr\/rxab014","type":"journal-article","created":{"date-parts":[[2021,9,7]],"date-time":"2021-09-07T14:31:55Z","timestamp":1631025115000},"page":"22-24","source":"Crossref","is-referenced-by-count":10,"title":["Secukinumab therapy in reactive arthritis: Report of two cases"],"prefix":"10.1093","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2545-9032","authenticated-orcid":false,"given":"Prasanta","family":"Padhan","sequence":"first","affiliation":[{"name":"Department of Clinical Immunology and Rheumatology, Kalinga Institute of Medical Sciences, KIIT University, Bhubaneswar, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8093-8303","authenticated-orcid":false,"given":"Debashis","family":"Maikap","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology and Rheumatology, Kalinga Institute of Medical Sciences, KIIT University, Bhubaneswar, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,8,11]]},"reference":[{"key":"2022011123194514900_R1","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s10067-007-0692-0","article-title":"Successful use of infliximab in the treatment of Reiter\u2019s syndrome: a case report and discussion","volume":"27","author":"Gill","year":"2008","journal-title":"Clin Rheumatol"},{"key":"2022011123194514900_R2","doi-asserted-by":"crossref","DOI":"10.4103\/ijdvl.IJDVL_519_18","article-title":"A retrospective case series of 12 patients with chronic reactive arthritis with emphasis on treatment outcome with biologics","volume":"87","author":"Gupta","year":"2021","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"2022011123194514900_R3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/ard.38.Suppl_1.73","article-title":"Incomplete Reiter\u2019s syndrome: clinical comparisons with classical triad","volume":"38","author":"Arnett","year":"1979","journal-title":"Ann Rheum Dis"},{"key":"2022011123194514900_R4","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1128\/CMR.17.2.348-369.2004","article-title":"HLA-B27-associated reactive arthritis: pathogenetic and clinical considerations","volume":"17","author":"Colmegna","year":"2004","journal-title":"Clin Microbiol Rev"},{"key":"2022011123194514900_R5","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20191927","article-title":"Treatment of reactive arthritis with biological agents: a review","volume":"40","author":"Zeng","year":"2020","journal-title":"Biosci Rep"},{"key":"2022011123194514900_R6","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.3899\/jrheum.080395","article-title":"Influence of HLA-B* 5703 and HLA-B* 1403 on susceptibility to spondyloarthropathies in the Zambian population","volume":"35","author":"Diaz-Pena","year":"2008","journal-title":"J Rheumatol"},{"key":"2022011123194514900_R7","first-page":"2285","article-title":"Th1\/Th17 cytokine profiles in patients with reactive arthritis\/undifferentiated spondyloarthropathy","volume":"34","author":"Singh","year":"2007","journal-title":"J Rheumatol"},{"key":"2022011123194514900_R8","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nm.2817","article-title":"IL-23 induces spondyloarthropathy by acting on ROR-\u03b3t\u2009+\u2009CD3+ CD4\u2013CD8\u2013 entheseal resident T cells","volume":"18","author":"Sherlock","year":"2012","journal-title":"Nat Med"},{"key":"2022011123194514900_R9","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-016-0949-6","article-title":"IL-23\/Th17 axis is not influenced by TNF-blocking agents in ankylosing spondylitis patients","volume":"18","author":"Milanez","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"2022011123194514900_R10","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1002\/art.41042","article-title":"2019 update of the American College of Rheumatology\/Spondylitis Association of America\/Spondyloarthritis Research and Treatment Network recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis","volume":"71","author":"Ward","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"2022011123194514900_R11","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1002\/art.40581","article-title":"Brief report: interleukin-17 blockade with secukinumab in peripheral spondyloarthritis impacts synovial immunopathology without compromising systemic immune responses","volume":"70","author":"Van Mens","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"2022011123194514900_R12","first-page":"S","article-title":"TNF involvement and anti-TNF therapy of reactive and unclassified arthritis","volume":"20","author":"Meador","year":"2002","journal-title":"Clin Exp Rheumatol"}],"container-title":["Modern Rheumatology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mrcr\/advance-article-pdf\/doi\/10.1093\/mrcr\/rxab014\/41745850\/rxab014.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mrcr\/article-pdf\/6\/1\/22\/42106732\/rxab014.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mrcr\/article-pdf\/6\/1\/22\/42106732\/rxab014.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T02:47:00Z","timestamp":1642560420000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mrcr\/article\/6\/1\/22-24\/6348240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,11]]},"references-count":12,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,8,11]]},"published-print":{"date-parts":[[2022,1,7]]}},"URL":"https:\/\/doi.org\/10.1093\/mrcr\/rxab014","relation":{},"ISSN":["2472-5625"],"issn-type":[{"value":"2472-5625","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,1,1]]},"published":{"date-parts":[[2021,8,11]]}}}